Robert S Radie
CIK 1591113 · Principal Financial Officer · last filed 2025-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$89.7K
Companies
3
Total Filings
43
Lifetime Open-Market Net
-$1.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RMTI | Director | 143,525 | $0.62 | $89.7K | $0 | 7 | 2025-05-21 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Director | 20,000 | $2.23 | $44.6K | -$69.4K | 12 | 2023-09-21 |
| Zyla Life Sciences (EGLT) Delisted | President and CEO | 834,900 | — | — | -$1.85M | 21 | 2018-06-15 |
Recent Filings · Page 3 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-07 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Sell (S) | −3,000 | -$42.7K | EDGAR |
| 2017-06-12 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-06 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2016-12-13 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-08 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-04 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −15,000 | -$112.0K | EDGAR |
| 2016-07-06 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −15,000 | -$75.2K | EDGAR |
| 2016-06-17 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-06 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −5,000 | -$35.0K | EDGAR |
| 2016-04-05 | Zyla Life Sciences (EGLT) Delisted | Sell (S) | −10,000 | -$69.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.